XML 57 R35.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingencies - Additional Information (Detail)
1 Months Ended 12 Months Ended
Mar. 31, 2019
USD ($)
Dec. 31, 2015
USD ($)
Nov. 30, 2015
USD ($)
shares
Dec. 31, 2020
USD ($)
ft²
OfficeSpace
Milestone
Dec. 31, 2019
USD ($)
Milestone
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Other Commitments [Line Items]              
Rental expense       $ 207,000 $ 188,000    
Debt outstanding       0      
Future payment under short term 2021       $ 33,000      
Number of Milestones Achieved | Milestone       0 0    
Indemnification obligations amount       $ 0      
Contingent liabilities       $ 0 $ 0    
Research and Development Expenses [Member]              
Other Commitments [Line Items]              
Milestone payment $ 300,000            
License Agreement [Member]              
Other Commitments [Line Items]              
Sales based milestone payment   $ 36,000,000          
Royalty payment period   8 years          
Office of Chief Scientist of Israeli Ministry of Economy and Industry [Member]              
Other Commitments [Line Items]              
Grants received   $ 537,000          
Scientific Development and Research, Inc. and Otodyne, Inc. [Member] | License Agreement [Member]              
Other Commitments [Line Items]              
License fees paid     $ 750,000        
Common stock, number of shares sold | shares     9,780        
ALS Therapy Development Foundation, Inc. License Agreement [Member]              
Other Commitments [Line Items]              
Fee due for milestones achieved           $ 1,000,000 $ 1,000,000
Common stock issued in lieu of making a cash payment           $ 1,000,000 $ 1,000,000
Number of Milestones Achieved | Milestone       0 0    
Remaining milestone payments for first licensed product       $ 6,000,000      
Annual License Maintenance Fee       100,000      
ALS Therapy Development Foundation, Inc. License Agreement [Member] | Achievement of 500 Million Aggregate Sales [Member]              
Other Commitments [Line Items]              
Reaching of aggregate net sales       500,000,000      
Amount of one-time milestone payment       15,000,000      
ALS Therapy Development Foundation, Inc. License Agreement [Member] | Achievement of 1 Billion Aggregate Sales [Member]              
Other Commitments [Line Items]              
Reaching of aggregate net sales       1,000,000,000      
Amount of one-time milestone payment       $ 30,000,000      
Minimum [Member]              
Other Commitments [Line Items]              
Remaining term of office lease       9 months      
Minimum [Member] | License Agreement [Member]              
Other Commitments [Line Items]              
Sales required to achieve milestone payment   1,000,000,000          
Maximum [Member]              
Other Commitments [Line Items]              
Remaining term of office lease       1 year      
Maximum [Member] | License Agreement [Member]              
Other Commitments [Line Items]              
Development and regulatory milestone payments   $ 42,100,000          
Maximum [Member] | ALS Therapy Development Foundation, Inc. License Agreement [Member]              
Other Commitments [Line Items]              
Development and regulatory milestone payments       $ 2,500,000      
Irvine, California              
Other Commitments [Line Items]              
Area of office space | ft²       5,197      
Lease expiration date       Sep. 30, 2021      
Burlington, Massachusetts              
Other Commitments [Line Items]              
Lease expiration date       Jun. 30, 2021      
Number of office spaces operating lease | OfficeSpace       4